Filing Flows › Companies › Pediatrix Medical Group › Timeline
Pediatrix Medical Group stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+43.4% to $31.29
Pediatrix Medical Group (MD) stock rose 43% over the last 252 sessions, to $31.29. On the way it reported 4 quarters, its insiders filed 4 open-market trades and 4 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Oct 29, 2026 | Earnings | Earnings: beat the EPS estimate by 10.8% | +0.9% (+1.3% vs SPY) | +12.6% (+13.3% vs SPY) | — |
| Sep 11, 2026 | Form 144 | Form 144: Mary Ann E Moore plans to sell $573K | +0.2% (−0.7% vs SPY) | −4.7% (−5.4% vs SPY) | −0.3% (−3.3% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: Laura Linynsky plans to sell $161K | −1.3% (−0.7% vs SPY) | −3.6% (−2.5% vs SPY) | −3.2% (−5.0% vs SPY) |
| Aug 14, 2026 | Form 144 | Form 144: Sylvia Young plans to sell $492K | +0.9% (+1.1% vs SPY) | −0.6% (+1.4% vs SPY) | +2.0% (+4.2% vs SPY) |
| Aug 14, 2026 | Form 144 | Form 144: Mary Ann E Moore plans to sell $246K | +0.9% (+1.1% vs SPY) | −0.6% (+1.4% vs SPY) | +2.0% (+4.2% vs SPY) |
| Aug 4, 2026 | Earnings | Earnings: beat the EPS estimate by 6.6% | −6.0% (−7.8% vs SPY) | −0.6% (−2.7% vs SPY) | +0.8% (+0.3% vs SPY) |
| Jul 24, 2026 | 8-K | Directors and officers: departures, appointments, pay | −0.5% (−0.5% vs SPY) | +0.9% (−0.2% vs SPY) | +1.3% (−2.0% vs SPY) |
| May 13, 2026 | Insider sale | Weis Shirley A sold $856K | +1.3% (+0.7% vs SPY) | −2.9% (−2.3% vs SPY) | +2.0% (+2.1% vs SPY) |
| May 7, 2026 | 8-K | Directors and officers: departures, appointments, pay | +2.5% (+1.7% vs SPY) | +2.4% (+0.1% vs SPY) | −2.0% (−3.1% vs SPY) |
| May 5, 2026 | Earnings | Earnings: beat the EPS estimate by 16.1% | −7.3% (−8.1% vs SPY) | +4.2% (+1.3% vs SPY) | −2.6% (−7.5% vs SPY) |
| Feb 19, 2026 | Earnings | Earnings: missed the EPS estimate by -7.1% | −13.0% (−12.7% vs SPY) | −9.9% (−10.9% vs SPY) | −10.0% (−6.0% vs SPY) |
| Dec 15, 2025 | Insider sale | Ordan Mark S sold $515K | +0.8% (+1.0% vs SPY) | −2.7% (−2.8% vs SPY) | −2.2% (−3.7% vs SPY) |
| Nov 17, 2025 | Insider sale | Rucker Michael A. sold $241K | −0.6% (+0.4% vs SPY) | −0.2% (+1.7% vs SPY) | −3.6% (−4.7% vs SPY) |
| Nov 6, 2025 | Insider sale | Linynsky Laura A sold $216K | +0.6% (+1.7% vs SPY) | +4.5% (+3.7% vs SPY) | +2.0% (+0.8% vs SPY) |
Insiders’ record here
In the year on the chart, Pediatrix Medical Group's insiders reported 0 open-market buys ($0) and 4 sales ($1.8M). Of the 4 old enough to score, 3 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −7.8%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Pediatrix Medical Group: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.